| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.2B | $2.9B | $2.6B | $2.3B | $0.5B | $0.8B | $0.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | $0.6B | $0.6B |
| Net Income | $-1.1B | $0.3B | $-0.0B | $0.3B | $0.2B | $-0.8B | $-0.0B | $-0.3B |
| EPS (Basic) | $-12.16 | $2.79 | $-0.24 | $3.05 | $2.15 | $-8.91 | $-0.13 | $-3.80 |
| EPS (Diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-8.78 | $-0.13 | $-3.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.5B | $6.0B | $5.4B | $5.0B | $4.8B | $6.5B | $6.9B | $6.2B |
| Current Assets | $0.8B | $0.6B | $0.6B | $0.5B | $0.5B | $2.5B | $0.5B | $0.5B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | $3.4B | $2.8B | $2.5B | $2.1B | $2.2B | $4.5B | $4.3B | $3.8B |
| Current Liabilities | $0.5B | $0.6B | $0.9B | $0.4B | $0.4B | $1.3B | $0.5B | $0.4B |
| Stockholders' Equity | $1.9B | $3.1B | $2.8B | $2.8B | $2.5B | $1.9B | $2.5B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.5B | $0.4B | $0.4B | $0.7B | $0.3B | $0.4B |
| Investing Cash Flow | $-0.6B | $-0.7B | $-0.4B | $-0.3B | $1.0B | $-0.3B | $-0.2B | $-0.4B |
| Capital Expenditures | $0.6B | $0.7B | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B |
| Financing Cash Flow | $0.5B | $0.6B | $-0.1B | $-0.1B | $-1.6B | $-0.1B | $-0.1B | $-0.1B |